U.S. Packaging Stock News

Coherent (NYSE:COHR) announced that Chief Strategy Officer Giovanni Barbarossa will transition from his role and retire in September 2026. Barbarossa will serve as Special Advisor to the CEO until his retirement, supporting continuity during the leadership change. The announcement comes alongside Coherent reporting revenue and earnings growth across its business. Coherent is a supplier of advanced optics and laser technologies that are used in AI infrastructure, communications, and...

QuidelOrtho (QDEL) opened Q1 2026 with revenue of US$619.8 million and a basic EPS loss of US$1.35, while trailing 12 month figures show revenue of US$2.66 billion against a basic EPS loss of US$17.81. Over the past six reported quarters, revenue has ranged from US$613.9 million to US$723.6 million, and quarterly basic EPS has moved between a loss of US$0.19 and a loss of US$10.78. This leaves investors focused on how much of today’s revenue base can ultimately translate into more stable...

Hinge Health (HNGE) opened Q1 2026 with revenue of $182.3 million and basic EPS of $0.43, providing a clear view of how the business is currently converting its top line into per share results. Over the past year, the company has reported quarterly revenue of $117.3 million in Q4 2024, $123.8 million in Q1 2025, $139.1 million in Q2 2025, $154.2 million in Q3 2025, $170.7 million in Q4 2025 and now $182.3 million in Q1 2026. Basic EPS over the same period has ranged from $1.98 to $7.38,...

Phibro Animal Health Corporation has reported its third-quarter 2026 results, with sales of US$383.54 million and net income of US$24.02 million, alongside the launch of its Sustainable Solutions Platform and Verratain™ low‑carbon feed products in partnership with VAXA Technologies. The combination of stronger earnings and a companywide push into emissions‑focused feed ingredients suggests Phibro is tying profitability more closely to sustainability trends across animal protein and petfood...

Bloomin' Brands (BLMN) opened 2026 with Q1 revenue of US$1.1b and basic EPS of US$0.65, setting the tone for how investors will read its latest earnings story against a current share price of US$8.12. The company has seen quarterly revenue move from US$972.0m in Q4 2024 to US$1.1b in Q1 2026, while basic EPS has ranged from US$0.13 in Q4 2024 to a loss of US$0.54 in Q3 2025 and then back to US$0.65 in the latest quarter. This puts the focus squarely on how durable any margin recovery really...

Coty (COTY) Q3 2026: Earnings Snapshot Coty (COTY) has just posted its Q3 2026 numbers, with revenue of US$1.3 billion, basic EPS of a US$0.47 loss, and a net income loss of US$411.4 million setting the tone for the quarter. Over recent periods the company has seen quarterly revenue move from US$1.3 billion in Q3 2025 to US$1.3 billion in Q3 2026, with basic EPS unchanged at a US$0.47 loss. Trailing twelve month EPS stand at a US$0.62 loss and net income at a US$545.8 million loss, which...

Millrose Properties (MRP) opened Q1 2026 with total revenue of US$194.9 million and basic EPS of US$0.74, while trailing 12 month revenue stood at US$712.7 million and EPS at US$2.79 as the company continued to build on its recent return to profitability. The company has seen revenue move from US$82.7 million in Q1 2025 to US$194.9 million in Q1 2026, with basic EPS shifting from US$0.39 to US$0.74 over the same period. This sets up a story where investors are weighing the earnings recovery...

Oscar Health (OSCR) has opened 2026 with a sharp swing into profitability in its latest quarter, posting Q1 revenue of about US$4.6 billion alongside basic EPS of US$2.28 on net income of roughly US$679 million, versus Q1 2025 revenue of about US$3.0 billion and EPS of US$1.10. Over the trailing twelve months to Q1 2026, revenue has moved from roughly US$9.2 billion to about US$13.3 billion, while EPS on the same basis shifted from US$0.11 to a small loss of US$0.14, highlighting how the...

Teradata (TDC) opened 2026 with Q1 revenue of US$444 million and basic EPS of US$3.60, against a backdrop of trailing 12 month revenue of US$1.69 billion and EPS of US$4.48, where earnings over that period are reported to have grown very strongly year over year. Over recent quarters, revenue has moved from US$409 million in Q4 2024 to US$418 million in Q1 2025 and US$421 million in Q4 2025, while quarterly EPS has ranged between roughly US$0.09 and US$0.46 before this latest jump. This sets...

Earnings and convertible notes set the stage for Ocugen stock Ocugen (OCGN) is back in focus after reporting first quarter 2026 results and closing a US$103.5 million convertible note offering, a combination that puts both its cash needs and capital structure in the spotlight. See our latest analysis for Ocugen. The recent 1 day share price return of 2.35% decline and 7 day share price return of 13.39% decline suggest some short term profit taking after the earnings release and convertible...

White Mountains Insurance Group (WTM) opened 2026 with Q1 revenue of US$517.8 million and a basic EPS loss of US$12.59. This compares with basic EPS of US$13.22 on revenue of US$577.8 million in Q1 2025. Trailing twelve month revenue is US$3.7 billion and basic EPS is US$423.13. Over recent quarters, revenue has ranged from US$358 million in Q4 2024 to US$1.6 billion in Q4 2025. Basic EPS has moved from a loss of US$50.16 in Q4 2024 to US$322.14 in Q4 2025. This context frames a Q1 2026 print...

Hyster-Yale (HY) opened Q1 2026 with revenue of US$795.2 million and a basic EPS loss of US$1.71, while over the trailing 12 months revenue totaled US$3.7 billion with a basic EPS loss of US$5.59. Over recent quarters, the company has seen revenue move from US$910.4 million and EPS of US$0.49 in Q1 2025 to US$923.2 million and an EPS loss of US$2.96 in Q4 2025, before landing at the latest Q1 2026 levels. For investors, these results keep the focus squarely on how quickly margins can...

Global Industrial (GIC) just opened Q1 2026 with revenue of US$350.4 million and basic EPS of US$0.40, setting the tone for its latest update on profitability. The company has seen revenue move from US$321 million and EPS of US$0.35 in Q1 2025 to US$350.4 million and EPS of US$0.40 in Q1 2026. Trailing 12 month EPS sits at US$1.90 on US$1.4 billion of revenue, giving a clearer read on earnings power over a full year. With trailing net income of US$73 million and a net margin that has ticked...

Royalty Pharma (RPRX) opened 2026 with Q1 revenue of US$631 million and basic EPS of US$0.69, alongside trailing twelve month revenue of about US$2.4 billion and EPS of US$1.93 that sit against a net profit margin of 33.9%. Over recent quarters the company has seen revenue move from US$568 million in Q1 2025 to US$631 million in Q1 2026, while quarterly EPS has ranged between US$0.07 and US$0.69. This sets up a results snapshot where forecast revenue and earnings growth meet a thinner margin...

Atlas Energy Solutions (AESI) opened Q1 2026 with revenue of US$265.6 million and a basic EPS loss of US$0.38, as net income excluding extra items came in at a loss of US$47.3 million. The company has seen quarterly revenue move from US$297.6 million in Q1 2025 to US$265.6 million in Q1 2026, while basic EPS shifted from a profit of US$0.01 to a loss of US$0.38 over the same period. This sets up a mixed read on top line scale versus bottom line pressure. For investors, the story in this print...

BlackLine (NasdaqGS:BL) opened Q1 2026 with revenue of US$183.2 million and basic EPS of US$0.14, setting a clear marker for how its profitability story is evolving. The company reported revenue of US$169.5 million in Q4 2024 and US$183.2 million in Q1 2026, while quarterly basic EPS has ranged from US$0.08 to US$0.90 over that period, giving investors a detailed look at how margins are being earned rather than assumed. See our full analysis for BlackLine. With the headline figures on the...

Elanco Animal Health (ELAN) opened 2026 with Q1 revenue of about US$1.4b and basic EPS of US$0.11, alongside net income of US$57m, setting a cleaner profit picture against a still loss-making trailing twelve months. Over that period, basic EPS stands at a US$0.49 loss on revenue of US$4.9b and a net loss of US$242m. Over recent quarters the company has seen quarterly revenue move from US$1.02b in Q4 2024 to US$1.19b in Q1 2025 and then to US$1.37b in Q1 2026. Quarterly basic EPS shifted from...

Chemours (CC) has kicked off Q1 2026 with revenue of US$1.4 billion, a basic EPS loss of US$0.19 and net income excluding extra items of a US$29 million loss, with trailing 12 month figures showing revenue of US$5.8 billion and a net loss of US$410 million or basic EPS of US$2.79. Over recent quarters the company has seen revenue move from US$1.37 billion in Q1 2025 to US$1.38 billion in Q4 2025 and now US$1.4 billion, while quarterly basic EPS has ranged from a loss of US$2.54 in Q2 2025 to...

Holley Q1 2026 headline results Holley (HLLY) opened 2026 with Q1 revenue of US$147.3 million and basic EPS of US$0.06, alongside net income of US$7.3 million, putting fresh quarterly profits in focus for investors watching the stock around US$2.87. The company has seen quarterly revenue move from US$153.0 million and EPS of US$0.02 in Q1 2025 to US$147.3 million and EPS of US$0.06 in Q1 2026. Meanwhile, trailing 12 month EPS shifted from a loss of US$0.20 in Q1 2025 to a profit of US$0.20 in...

Andersons (ANDE) opened 2026 with Q1 revenue of US$2.6b and basic EPS of US$0.98, alongside net income of US$33.2m. Over the trailing twelve months it has produced revenue of US$11.0b, basic EPS of US$3.78 and net income of US$128.6m. The company has seen quarterly revenue move between US$2.5b and US$3.1b and basic EPS range from roughly US$0.01 to US$1.98 over the past year. This performance feeds into a trailing net margin of 1.2%, which puts the focus on how efficiently each dollar of...

Neurocrine Biosciences (NBIX) opened 2026 with Q1 revenue of US$814.5 million and basic EPS of US$1.97, while trailing 12 month figures sit at US$3.1 billion of revenue and EPS of US$6.71, setting a firm earnings-season backdrop. The company has seen quarterly revenue move from US$572.6 million in Q1 2025 to US$814.5 million in Q1 2026, with basic EPS shifting from US$0.08 to US$1.97 over the same period. Earnings growth of 118.6% over the past year and forecast EPS growth of about 21.1% per...

Oncolytics Biotech reported new durability and response data for its pelareorep therapy in RAS-mutant MSS metastatic colorectal cancer. The pelareorep-based regimen outperformed historical benchmarks in second-line treatment, with longer median duration of response and higher objective response rates. The company has initiated enrollment in a Phase 2 randomized study and is in active discussions with the FDA on a potential accelerated approval pathway. For investors watching NasdaqCM:ONCY,...

Aurora Innovation (NasdaqGS:AUR) has signed its first commercial contract for fully driverless long haul trucking with McLane Company. The partnership will use autonomous trucks to run driverless routes in Texas for a major national distributor. Aurora plans to scale to 200 fully driverless trucks and broaden its US route network by year end. Aurora Innovation focuses on autonomous driving technology, with trucking as a key commercial application. The McLane agreement moves the company from...

Limbach Holdings (LMB) has kicked off Q1 2026 with revenue of US$138.9 million and basic EPS of US$0.37, alongside trailing 12 month EPS of US$2.85 on revenue of US$652.6 million. This helps frame the latest quarter against a broader earnings base. Over recent quarters the company has seen revenue move from US$133.1 million in Q1 2025 to a peak of US$186.9 million in Q4 2025, while basic EPS ranged from US$0.67 to US$1.06 over that stretch. This provides a clearer view of how the top line has...